Dehydrovomifoliol Alleviates Nonalcoholic Fatty Liver Disease <i>via</i> the E2F1/AKT/mTOR Axis: Pharmacophore Modeling and Molecular Docking Study.

Ma, Ji; Li, Ruya; Xu, Fang; Zhu, Fang; Xu, Xiangwei

Dehydrovomifoliol Alleviates Nonalcoholic Fatty Liver Disease via the E2F1/AKT/mTOR Axis: Pharmacophore Modeling and Molecular Docking Study.

Ma, Ji; Li, Ruya; Xu, Fang; Zhu, Fang; Xu, Xiangwei.

Afiliação

Ma J; Department of Gastroenterology, The First People's Hospital of Yongkang, Affiliated to Hangzhou Medical College, Jinhua 321300, China.
Li R; Department of Pharmacy, The People's Hospital of Jinyun, Lishui 321400, China.
Xu F; Department of Gastroenterology, The First People's Hospital of Yongkang, Affiliated to Hangzhou Medical College, Jinhua 321300, China.
Zhu F; Department of Gastroenterology, The First People's Hospital of Yongkang, Affiliated to Hangzhou Medical College, Jinhua 321300, China.
Xu X; Department of Pharmacy, The First People's Hospital of Yongkang, Affiliated to Hangzhou Medical College, Jinhua 321300, China.

Evid Based Complement Alternat Med ; 2023: 9107598, 2023.

Article em En | MEDLINE | ID: mdl-36777627

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article